- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 278
Iguazio includes corporates in $33m series B
Verizon Ventures, Robert Bosch Venture Capital, Dell Technologies Capital and CME Ventures all invested in the data analytics technology provider, which is valued at $100m.
Jul 26, 2017Fosun clutches Teddy in series B round
Phone number recognition startup Teddy Mobile has now raised $29m in total, after securing an undisclosed amount in a round co-led by Fosun RZ Capital.
Jul 25, 2017Goldman Sachs provides $35m to Beqom
The Swisscom-backed cloud-based compensation software provider has received $35m in funding from Goldman Sachs Private Capital Investing.
Jul 25, 2017Pfizer helps expand Effector with series C funding
Pfizer Venture Investments led the small-molecule cancer drug developer's $38.6m series C round, which included Novartis, GlaxoSmithkline, AbbVie and Astellas.
Jul 25, 2017Graphcore frames $30m series B
Robert Bosch Venture Capital, Samsung Catalyst Fund and Dell Technologies Capital backed an Atomico-led round that doubled the machine intelligence startup's total funding.
Jul 21, 2017Dynamic Yield brings in extra series C funding
The personalised marketing technology producer has increased its series C to $31m, with Deutsche Telekom joining a round that already included Baidu.
Jul 21, 2017Boston Medical helps pour series B funds into Amphora
Medical device developer Amphora Medical has closed a $35.5m series B round co-led by Boston Scientific that will fund a pivotal study for its OAB treatment.
Jul 21, 2017Yissum-backed JII receives $25m
The Jerusalem Innovation Incubator is set to obtain $25m from Reliance Industries, which helped launch the project last month alongside Yissum and others.
Jul 21, 2017Alation logs $23m in series B
The collaborative data platform has closed a series B round that comes two years after a Bloomberg Beta-backed series A.
Jul 19, 2017PegBio clinches $20m in series E
Tasly Pharma has led a series E round for PegBio, which is working on drugs to treat diabetes and obesity, and which is also backed by Legend Holdings.
Jul 19, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


